Sveriges mest populära poddar
Conversations in Drug Development
Hälsa och motionMedicin

The Future of Drug Development: AI’s Role in Revolutionizing the Industry

22 min•8 november 2023

In this episode of Conversations in Drug Development, Dr. Julie Warner and Harriet Edwards discuss the revolutionizing role of artificial intelligence (AI) in drug development, exploring its applications in data analysis and toxicity prediction, and its potential to reduce animal testing. Join us in this conversation, as we discuss the challenges of regulating AI in this rapidly evolving field and the need for collaboration between regulators and developers. Is AI pushing the boundaries of what's possible? 

 

To discuss this episode of Conversations in Drug Development with a member of the team, visit www.boydconsultants.com.

Fler avsnitt av Conversations in Drug Development

Visa alla avsnitt av Conversations in Drug Development
Live Biotherapeutics: Navigating the Next Frontier in Drug Development
•32 min
UK Clinical Trial Regulation: What Sponsors Need to Know About UK CTR 2025
•26 min
How Will the EU Biotech Act Transform Biotechnology Regulation in Europe?
•30 min
Navigating the FDA Landscape: More Changes, and What's Next?
•27 min
At the forefront of innovation: Prof Alan Boyd reflects on the last 20 years in drug development
•40 min
Navigating the New FDA Landscape: Opportunities and Challenges Ahead
•36 min
From Lab to Launch – Avoiding the Pitfalls of Drug Development
•28 min
Crystal Ball Gazing: What Does the Future Hold for Regulatory Affairs in Drug Development for 2025
•33 min
How to Effectively De-Risk your IND Process
•53 min
Understanding EU Medical Device Regulations: Key Insights for Developers and Innovators
•24 min

Conversations in Drug Development med Boyds finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.